Board of Pharmacy
Chapter 855
Division 115
PHARMACISTS
855-115-0350
Services: Prescribing Practices - Short-acting Opioid Antagonists
(1) A Pharmacist may prescribe any FDA approved short-acting opioid antagonist (e.g., naloxone, nalmefene) and the necessary medical supplies to administer a short-acting opioid antagonist for opiate overdose:
(a) When dispensing any opiate or opioid prescription in excess of 50 morphine milligram equivalents (MME);
(b) To an individual seeking a short-acting opioid antagonist;
(c) To an entity seeking a short-acting opioid antagonist.
(2) A Pharmacist is not required to label the prescription according to OAR 855-041-1130 if dispensing a FDA approved short-acting opioid antagonist in the form of a nasal spray.
(3) The Pharmacist must document the encounter, the prescription and maintain records according to OAR 855-104-0055.
Statutory/Other Authority: ORS 689.205
Statutes/Other Implemented: ORS 689.305, ORS 689.681, ORS 689.682 & ORS 689.684
History:
BP 55-2024, amend filed 06/18/2024, effective 06/20/2024
BP 26-2023, adopt filed 10/16/2023, effective 03/01/2024